Dynavax Technologies Corporation logo
Dynavax Technologies Corporation DVAX

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Dynavax Technologies Corporation DSO Ratio 2011-2026 | DVAX

Annual DSO Ratio Dynavax Technologies Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
56.5 146 66 57.7 124 92.1 165 953 44.4 126 24.1 52.8 37.8 161

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
953 24.1 150

Quarterly DSO Ratio Dynavax Technologies Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
68.8 60 67.1 - 76.4 65.4 76.2 - 58.8 110 240 - - - - - 129 164 58.4 - 196 775 132 76.7 76.7 97.7 99.5 63.6 231 270 1.26 K 3.71 K 1.47 K 742 677 16.8 756 43.2 124 170 69.9 46.1 119 29.1 30 21.8 30.7 52.1 50.7 43.8 57.6 50.8 31.9 34.2 204 76.1 740 120 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3.71 K 16.8 279

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
2.94 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
29 - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
400 $ 2.22 - $ 207 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
559 $ 1.58 - $ 185 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
Celyad Oncology SA Celyad Oncology SA
CYAD
64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 29.93 - $ 1.99 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
IMV IMV
IMV
2.16 K - - $ 13.1 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.13 - $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
39.1 $ 28.9 - $ 778 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
3.66 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
76.5 $ 14.79 - $ 212 M usaUSA
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.16 - $ 5.2 M israelIsrael
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 56.95 - $ 5.12 B schweizSchweiz
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA